The C-terminal domain (CTD) of RNA polymerase II (RNAPII) is an essential component of transcriptional regulation and RNA processing of protein-coding genes. A large body of data also implicates the CTD in the transcription and processing of RNAPII-mediated small nuclear RNAs (snRNAs). However, the identity of the complex (or complexes) that associates with the CTD and mediates the processing of snRNAs has remained elusive. Here, we describe an RNA polymerase II complex that contains at least 12 novel subunits, termed the Integrator, in addition to core RNAPII subunits. Two of the Integrator subunits display similarities to the subunits of the cleavage and polyadenylation specificity factor (CPSF) complex. We show that Integrator is recruited to the U1 and U2 snRNA genes and mediates the snRNAs' 3 end processing. The Integrator complex is evolutionarily conserved in metazoans and directly interacts with the C-terminal domain of the RNA polymerase II largest subunit.
Introduction
Deleted in split hand/split foot 1 (DSS1), the product of a candidate gene for split hand/split foot, was initially identified as a small w10 kDa acidic protein that could directly interact with the C-terminal domain of the BRCA2 protein (Marston et al., 1999) . A more recent study examining the crystal structure of BRCA2 C-terminal domain with DSS1 revealed the importance of DSS1 in endowing the C terminus of BRCA2 with protein folds reminiscent of single-stranded nucleotide binding proteins (Yang et al., 2002) .
Most of the current data suggest that BRCA2 serves (Patel et al., 1998) . Surprisingly, a number of studies have also reported the intimate association of yeast and human DSS1 proteins with the 19S subcomplex of the proteasome, pointing to DSS1 as an evolutionarily conserved subunit of the proteasome complex (Funakoshi et al., 2004; Sone et al., 2004) . Interestingly, both DSS1 and the 19S proteasome have been shown to play roles in the pathways responsive to DNA damage (Krogan et al., 2004) . This is of particular interest since the BRCA2/DSS1 complex was also suggested to play a role in homology-directed DNA repair (Kojic et al., 2003 (Kojic et al., , 2005 .
To elucidate the molecular mechanism by which DSS1 induces its functional effects, we isolated the DSS1-containing complexes from HEK293-derived cell lines stably expressing Flag-DSS1 and identified its components by mass spectrometry. Here we show that DSS1 is a component of multiple distinct complexes. These complexes include the 19S proteasome, the BRCA2/RAD51 complex, and a novel multiprotein complex termed Integrator. The Integrator complex is associated with the C-terminal domain (CTD) of RNA polymerase II (RNAPII) largest subunit and mediates the 3# end processing of small nuclear RNAs U1 and U2.
Small nuclear RNAs (snRNAs) are components of the spliceosome, a complex assembly of ribonucleoparticles involved in pre-mRNA processing (Jurica and Moore, 2003) . The majority of snRNAs (i.e., U1 to U5) are transcribed by RNAPII to yield short nonpolyadenylated 3#-extended precursors (Eliceiri and Sayavedra, 1976; Wieben et al., 1985) . These precursors are then exported to the cytoplasm for further 3# trimming and incorporation into the small nuclear ribonucleoparticles (snRNPs) ( Our findings not only point to the immense intricacy of DSS1-containing complexes but also illuminate a novel RNAPII-containing multiprotein complex rivaling the Mediator in its complexity. Moreover, by defining the Integrator complex, we have uncovered the elusive complex responsive for the 3# end processing of RNAPIImediated snRNAs.
Results

The 19S Proteasome Is the Predominant DSS1-Containing Complex
To determine the polypeptide composition of the DSS1-containing complex (or complexes), we developed HEK293-derived cell lines stably expressing a Flagtagged DSS1 and purified DSS1-associated proteins by anti-Flag affinity purification ( Figure 1A) . To determine the identity of the DSS1-associated polypeptides, the Flag affinity eluate was separated on a polyacrylamide gel, bands were stained with colloidal blue, and individual polypeptides were excised from the gel and subjected to mass spectrometric analysis. This resulted in the identification of the 19S proteasome subunits as the main component of DSS1-associated polypeptides (see Table S1 in the Supplemental Data available with this article online). In addition, we obtained peptide sequences corresponding to BRCA2, RNA polymerase II (RNAPII), and a number of uncharacterized human open reading frames. Surprisingly, although the novel polypeptides do not display any homology to yeast genes, nearly all of the new DSS1-associated polypeptides have homologs in metazoans (Table S2) .
To establish the molecular mass of different DSS1-containing complexes, we fractionated the Flag-DSS1 eluate by gel filtration chromatography using 500 mM KCl. Analysis of gel filtration fractions by SDS-PAGE followed by Western blot analysis revealed the coelution of BRCA2, RNAPII, and the novel subunits described in Table S1 in a large complex of about 2 MDa, while the components of the 19S proteasome eluted with a smaller molecular mass of w700 kDa ( Figure 1B) . Taken together, these results demonstrate the occurrence of DSS1 as a component of distinct multiprotein complexes that could be partially resolved by gel filtration chromatography.
DSS1 Associates with a Set of Novel Polypeptides
Besides the subunits of the 19S proteasome and BRCA2, the novel polypeptides associated with DSS1 could be classified in two categories: a set of polypeptides that were found to be stably associated with RNAPII that were named Ints (Integrator, for integrating the CTD of RNAPII largest subunit with the 3# end processing of small nuclear RNAs U1 and U2) and two polypeptides (KIAA1932 and Sac3 homology domain 1) that contain domains predictive of a function in RNA transport but were not found to be in a stable complex with RNAPII (Table S1 ). Most Integrator polypeptides did not show significant homology with known proteins in the database. However, a closer examination of Int6, (Table S2) , we could not detect any homology for Integrator polypeptides in fungi.
Identification of the Integrator Complex as an Evolutionarily Conserved RNA Polymerase II-Containing Complex
To begin deciphering the polypeptide composition of different DSS1-containing complexes, we developed Table S1 ). A similar polypeptide composition was obtained following the analysis of Flag-Int11 ( Figure 2B ). In contrast, Flag-KIAA1932 affinity eluate was devoid of RNAPII or any Integrator subunits (Figure 2A ; peptide bands at 68, 55, and 34 kDa correspond to SKB1, α-tubulin, and MEP50 common contaminants of Flag purification). Moreover, despite a number of attempts and consistent with a previous report, we were unable to detect either Flag-DSS1 or endogenous DSS1 using Western blot analysis (Marston et al., 1999) . Furthermore, mass spectrometric analysis of Integrator subunits did not reveal any sequences corresponding to the BRCA2 protein.
Next we analyzed the Flag-Int11 affinity eluate by gel filtration. This analysis revealed the association of Integrator subunits and RNAPII in a large complex peaking in fractions 16 through 20, while a fraction of FlagInt11 eluted as a smaller complex, peaking at fraction 30, devoid of RNAPII (Figures 2C and 2D) To ask whether the Integrator complex can directly associate with the CTD, the Flag-Int11 affinity eluate was fractionated through an 8WG16 affinity chromatography column ( Figure 3A) . Analysis of the anti-CTD affinity flowthrough fraction revealed the presence of Integrator subunits, while the RNAPII was retained on the antibody column ( Figure 3A) .
To directly examine the association of the Integrator complex and the CTD, HeLa nuclear extract enriched for the Integrator complex following phosphocellulose (P11) chromatography (0.5 M KCl eluate) was subjected to affinity purification by a GST-CTD column. As a control, a fraction enriched for the ARC-S/CRSP/PC2/ Mediator complex (1.0 M KCl eluate) was also analyzed following binding to a GST-CTD column. While mass spectrometric analysis of the CTD affinity eluate derived from the 0.5 M P11 fraction revealed the association of a subcomplex of at least six Integrator subunits with the CTD, the eluate derived from the 1 M P11 fraction contained the ARC-S subcomplex of the Mediator complex ( Figure 3B) . Moreover, SDS-PAGE followed by silver-staining analysis of Flag-Int11 affinity eluate and Integrator subunits isolated by GST-CTD revealed a similar polypeptide composition ( Figure 3C ). It is likely that, similar to the Mediator complex, only a subcomplex of Integrator subunits can directly associate with the CTD of RNAPII, while other subunits of the Integrator complex may contact the RNAPII through other polymerase subunits (Bjorklund and Gustafsson, 2004 ).
The Integrator Complex Mediates RNA Polymerase II-Dependent Transcription and Occupies the Promoter of Two Small Nuclear RNA Genes
Since the Integrator complex can be isolated as a stable component of RNAPII, we asked whether the Integrator-RNAPII could mediate an RNAPII-dependent transcription reaction in a reconstituted transcription system using adenovirus type 2 as the template. As Figure 4A demonstrates, the Integrator-RNAPII complex could reconstitute transcription to the same levels as core RNAPII in an in vitro transcription system. However, ectopic expression of Integrator subunits or depletion of Integrator subunits using small interfering RNA (siRNA) transfections did not result in alteration of c-fos mRNA level or c-fos promoter activity during serum or EGF induction (data not shown). Moreover, we could not detect the Integrator complex at the c-fos promoter using chromatin immunoprecipitation (ChIP) (data not shown). This led us to examine other genes besides mRNAcoding genes whose expression is also mediated by RNAPII. One class of genes in which not only expression but also 3# end transcript processing is mediated through RNAPII includes the snRNA genes, U1 and U2. Indeed, the CTD of RNAPII is required for the transcription and processing of U1 and U2 snRNAs (Uguen and Murphy, 2003). Therefore, we examined the promoter and coding region of U1 and U2 genes for the presence of the Integrator complex and RNAPII using ChIP (Figures 4B-4E) . The ChIP signals centered on the promoter and 3# regions of U1 and U2 genes were specific and equally strong ( Figure 4C ). We also compared the association of Integrator with the U2 and the high copy number histone H3 genes ( Figure 4D ). This analysis revealed the specific association of Integrator with the U2 gene ( Figure 4D) . Moreover, comparison of stable cell lines expressing Flag-Int10 or Flag-KIAA1932 using Flag antibody for ChIP revealed the specific association of Integrator with U1 and U2 genes only in cells expressing Flag-Int10 ( Figure 4E ). While these results indicate that the Integrator-RNAPII complex is recruited to the U1 and U2 snRNA genes, due to the low resolution of ChIP, we cannot determine with certainty whether the Integrator is occupying the promoter, the 3# region of the U1 and U2 genes, or both.
The Integrator Complex Mediates the 3 End Processing of U1 and U2 snRNAs
To ask whether the Integrator complex plays a role in snRNA processing, we used RNA interference to deplete Int11 (the predicted catalytic engine of the Integrator) or Int1 (the largest subunit of the Integrator complex). Processing of U1 and U2 small RNAs was assessed by T1 ribonuclease protection ( Figure 5A ). Analysis of U1 and U2 primary transcripts after Int11 depletion ( Figure 5B ) revealed a pronounced accumulation of the primary transcript, consistent with a defect in the processing of the 3# end of the U1 and U2 snRNA transcripts ( Figure 5C ). Similar results were obtained when the Int1 subunit of the complex was depleted using two different siRNAs (Figures 5D and 5E ). Accumulation of this transcript represents the extension of primary transcript beyond its natural processing site located upstream from the 3# box (Eliceiri and Sayavedra, 1976; Wieben et al., 1985) . Moreover, the defect in the 3# end processing did not result in decreased levels of mature U1 and U2 transcripts, consistent with the reported long half-life of RNAPII-transcribed spliceosomal snRNAs (U1, U2, U4, and U5) exceeding 60 hr (Fury and Zieve, 1996) . Finally, while depletion of Int11 or Int1 resulted in the accumulation of U2 primary transcript, there was no change in the GAPDH primary transcript ( Figure 5F ).
Int11 Is the Catalytic Subunit of the Integrator Complex
To directly assess the Int11 catalytic activity in mediating the 3# end processing, we constructed HEK293-derived stable cell lines expressing a mutant Int11 (E203Q) ( Figure 6A ) predicted to abrogate the catalytic activity of the β-lactamase domain by disruption of an ion-chelating residue in the active site of the enzyme (Ryan et al., 2004) . Isolation of the Flag-Int11 (E203Q) complex confirmed the association of Int11 (E203Q) with the other subunits of the Integrator and RNAPII complex ( Figure 6B) . Similarly, ChIP analysis confirmed the specific association of the Flag-Int11 (E203Q) with both the promoter and the 3# end of U1 and U2 snRNA genes ( Figure 6C ). We then analyzed the effect of Int11 (E203Q) overexpression on 3# end processing of U1 and U2 primary transcripts. Consistent with results obtained following depletion of Int11, Int11 (E203Q) cell lines displayed a pronounced defect in processing of U1 and U2 primary transcripts ( Figure 6D ). Taken together, these results demonstrate a role for Int11 catalytic activity in the processing of U1 and U2 snRNA genes. These results clearly suggest a scenario implicating a cotranscriptional mechanism in the 3# end processing of U1 and U2 snRNAs. This is consistent with our identification of the Integrator as the complex that may be recruited to the promoter of snRNA genes through its interaction with the CTD of RNAPII and mediates the snRNAs' 3# end processing. This contention is consistent with a plausible model shown in Figure 7 , representing a mechanism where Integrator is loaded on the RNAPII at the promoter, traveling with it along the gene and cleaving the nascent primary transcript, most likely by recognizing the 3# box at the end of the transcript (Figure 7) . Following the cleavage of the primary transcript by Integrator, the newly transcribed U snRNA is exported to the cytoplasm for 3# end trimming and incorporation into the snRNPs.
Discussion
Experimental Procedures Affinity Purification of Flag-Tagged Proteins
Flag-fusion-expressing plasmids and a selectable marker for puromycin resistance were cotransfected in HEK293T cells. Transfected cells were grown in presence of 5 g/ml puromycin (Sigma) for selection. Individual colonies were isolated and screened for Flagfusion-protein expression. Nuclear extracts of Flag-fusion-expressing cells (50 mg) were incubated with 250 l of anti-Flag M2 affinity gel (Sigma) for 2 hr at 4°C. Beads were washed with 4 × 10 ml BC500 buffer (20 mM Tris [pH 8], 0.5 M KCl, 10% glycerol, 1 mM EDTA, 1 mM DTT, 0.1% NP40, 0.5 mM PMSF, aprotinin, leupeptide, and pepstatin, 1 g/ml each) and one time with 10 ml BC100 buffer (20 mM Tris [pH 8], 0.1 M KCl, 10% glycerol, 1 mM EDTA, 1 mM DTT, 0.1% NP40, aprotinin, leupeptide, and pepstatin, 1 g/ml each). Bound peptides were eluted with 400 g/ml Flag peptide (Sigma) in BC100 buffer. For size-exclusion chromatography, peptides were loaded onto a Superose 6 HR 10/30 column equilibrated with BC500 (Flag-DSS1) or BC300 buffer (Flag-Int11). Flow rate was fixed at 0.35 ml/min, and 0.5 ml fractions were collected.
Immunoblot Analysis
After separation by SDS-PAGE, proteins were transferred to a PVDF membrane. Membranes were blocked with TTBS (10 mM Tris [pH 7.4], 150 mM NaCl, 0.05% Tween 20) plus 5% nonfat dry milk. Antibodies were diluted in TTBS. Primary antibodies were detected using phosphatase-conjugated anti-IgG antibodies (Promega).
Anti-Int2 and anti-Int9 polyclonal antibodies were raised against the following peptides: Int2, VDVVCLASLSDPELR; Int9, GWSLKD GNAFLDKELKE. Anti-BRCA2 monoclonal antibodies were raised against the C-terminal part of BRCA2 fused to GST. Anti-RNA polymerase II antibodies were a kind gift of D. Reinberg. Anti-Flag M2, 8WG16 ascites, and anti-RAD51 antibodies were purchased from Sigma, Covance, and Upstate Biotechnology (Lake Placid, NY), respectively.
Plasmid Constructs
Full-length cDNAs for DSS1, Int11, Int10, and KIAA1932 were amplified by standard PCR techniques and cloned into a pFlag-CMV2 (Sigma) vector.
For RNA probe synthesis, sequences of U1 and U2 snRNA and GAPDH gene were amplified using the following oligonucleotides: U1, forward primer 5#-CCTGCGATTTCCCCAAATG-3# and reverse primer 5#-GATATGACCCTTAGCGTACAG-3#; U2, forward primer 5#-CTGATACGTCCTCTATCCGAGGAC-3# and reverse primer 5#-CAA GCCGCCCCGCAGGTGCTAC-3#; GAPDH, forward primer 5#-GGA AGAGAGAGACCCTCACTGC-3# and reverse primer 5#-CCTTGA CACAAGCCCAGCTTCC-3#. PCR products were cloned into pCRII-TOPO (Invitrogen).
Generation of GST-CTD Fusion Protein
The GST-CTD fusion protein was expressed in Escherichia coli BL21 (DE3) and purified over glutathione-coupled resin (Pharmacia) as described (Naar et al., 2002) .
Purification of CTD Binding Polypeptides
HeLa nuclear extract (100 ml) was applied to a 50 ml P11 phosphocellulose (PC) column pre-equilibrated with 0.1 M KCl HEG (20 mM HEPES [pH 7.6], 0.1 mM EDTA, 10% glycerol, 1 mM DTT, 1 mM benzamidine, 0.25 mM PMSF, 2 g/ml aprotinin). The column was step eluted using two column volumes of 0.3 M, 0.5 M, and 1.0 M KCl HEG. The fractions were then dialyzed to 0.1 M KCl. Largescale purification of GST-CTD binding polypeptides was achieved by incubating 50 ml of the PC 0.5 M or 1 M fractions (precleared with GST beads twice for 1 hr) with 1 ml of GST-CTD-coupled beads for 3 hr nutating at 4°C. The beads were washed with 7 × 15 ml of 0.5 M KCl HEG plus 0.1% NP40 (HEGN) followed by two washes with 0.1 M KCl HEGN. Bound proteins were eluted by incubating twice with 0.5 ml of 0.3% sarkosyl in 0.1 M KCl HEGN for 1 hr nutating at 4°C. The eluted material was analyzed using SDS-PAGE and silver staining.
CTD Binding Polypeptide Microsequencing
Concentrated GST-CTD-purified proteins were separated by SDS-PAGE and transferred to a PVDF membrane. After Ponceau S staining, the bands were excised and subjected to trypsin digestion followed by HPLC separation of peptides. The purified peptides were then analyzed by microsequencing, and sequences were used to search the GenBank database using the BLAST program.
In Vitro Transcription Assay
In vitro transcription assays were carried out using an AdML promoter and purified transcription factors as previously described (Gerber et al., 2001 ). Transcriptional activity of increasing amounts of Integrator complex was compared with that of RNA polymerase II purified from HeLa cell nuclear extract. Site-Directed Mutagenesis E203Q mutation in Int11 was introduced using the QuikChange Site-Directed Mutagenesis Kit (Stratagene). The sequence of the upper-strand oligonucleotide used was 5#-CCTGCTCATCACACA GTCCACGTACGCCAC-3#.
RNA Synthesis
RNA probes, internally labeled with [α-32 P]CTP, were transcribed using T7 RNA polymerase (Riboprobe System, Promega). U1 or U2 DNA templates were generated by PCR from the U1 and U2 pCRII-TOPO plasmids (see Plasmid Constructs) using M13 reverse primer (Invitrogen) and U1 forward primer 5#-CCTGCGATTTCCCCAAATG-3# or U2 forward primer 5#-CTGATACGTCCTCTATCCGAGGAC-3#, respectively. GAPDH template was generated the same way using M13 forward and M13 reverse primers. After synthesis, RNA probes were purified by 6% polyacrylamide-7 M urea gel electrophoresis and extracted after 2 hr at 65°C in elution buffer (RPA III kit, Ambion).
Ribonuclease Protection Assay
Total RNAs were extracted from siRNA-treated HeLa cells using Trizol Reagent (Invitrogen). After purification, RNAs were further treated with 10 units of RNase-free DNase I (Roche), phenol/chloroform extracted and ethanol precipitated. Ribonuclease protection assays were performed using RNase T1 (RPA III kit, Ambion) according to manufacturer's recommendations. Ten micrograms of total RNA were used for each reaction. Hybridizations were performed overnight at 42°C, and RNA hybrids were digested 30 min at 37°C with RNase T1 (1/50 dilution). Protected fragments were resolved by 6% polyacrylamide-7 M urea gel electrophoresis. Gels were transferred to Whatman paper, dried, and autoradiographed, and band intensities were quantified using a phosphorimager.
RT-PCR cDNAs were synthesized from 2 g of total RNA using random primers and Superscript II reverse transcriptase (First-Strand Synthesis System, Invitrogen) at 42°C for 50 min. cDNAs were detected by PCR using the following primers: GAPDH (22 cycles), forward primer 5#-TCTGCCCCCTCTGCTGATGC-3#, reverse primer 5#-TTC TGGGTGGCAGTGATGGC-3#; Int1 (30 cycles), forward primer 5#-GGACAAGAATTACATGGCCC-3#, reverse primer 5#-CTTTGGTTT GGGTGCCTCTG-3#; Int11 (30 cycles), forward primer 5#-ACC CAGGCCATCTGCCCCATCTTGC-3#, reverse primer 5#-GGCGGC ACTTGTCAATCCAGGCAGC-3#. PCR products were resolved by 2% agarose gel electrophoresis and visualized with ethidium bromide (Sigma) under UV illumination.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation (ChIP) assays were performed by using a modified protocol from Upstate Biotechnology. Cells in a 10 cm dish were fixed at 37°C for 10 min with 1% formaldehyde. After crosslinking, cells were washed, harvested, and resuspended in 300 l SDS lysis buffer and sonicated under conditions yielding fragments ranging from 200 to 1000 bp. Samples were diluted ten times with ChIP dilution buffer and precleared for 2 hr at 4°C with recombinant protein A agarose beads (Repligen) coated with BSA, salmon-sperm DNA, and tRNA. Precleared lysates were used for an overnight immunoprecipitation using 5 g (IgG or M2) or 10 l (8WG16 ascites) of specific antibodies at 4°C. Complexes were collected for 1 hr using recombinant protein A agarose beads (Repligen) coated with BSA, salmon-sperm DNA, and tRNA. After washing, complexes were eluted for 1 hr at room temperature in elution buffer (1% SDS, 0.1 M NaHCO 3 ), and formaldehyde crosslinking was reversed overnight at 65°C. Eluted DNA was recovered through QIAquick columns (QIAGEN) and used as a template for PCR. The PCR primer sequences are the following: U1-A, forward primer 5#-GGAAGTGAGAATCCCAGCTG-5#, reverse primer 5#-CCC TGCCAGGTAAGTATGAG-3#; U1-B, forward primer 5#-CGTACGC CAAGGGTCATGTC-3#, reverse primer 5#-CGTCGCTTTTTCTCCTAT GGC-3#; U2-A, forward primer 5#-TGTAAGGGCGTCAATAGCGC-3#, reverse primer 5#-TAGCCAAAGGCCGAGAAGC-3#; U2-B, forward primer 5#-GGGAGGTGAGAGACGGTAGC-3#, reverse primer 5#-CGC ACATCAGGAACCTCACG-3#; GAPDH-5#, forward primer 5#-CCCGG TTTCTATAAATTGAGCCCG-3#, reverse primer 5#-GTTTCTCTCCG CCCGTCTTC-3#; GAPDH-cds, forward primer 5#-GTAAGGAGATGC TGCATTCG-3#, reverse primer 5#-AGAGGCAAGAAGGCATGAGG-3#; GAPDH-3#, forward primer 5#-GCCATGTAGACCCCTTGAAG-3#, reverse primer 5#-CCCAGACCCTAGAATAAGAC-3#, cell-cycle-dependent histone H3, forward primer 5#-GCGGTGATGGCGCTGCAGG AGGC-3#, reverse primer 5#-GCGAGCTGGATGTCTTTGGGCAT-3#.
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